Sunnyvale, CA, (December 18,
2008)
Impac Software, part of the Elekta Group and provider of software
solutions for anatomic pathology (AP) laboratories, today
announced that PowerPath’s synoptic reporting tool, version
9.2.5 and higher, has received certification from Cancer Care
Ontario (CCO). The certification formally authorizes the company
as a vendor that can assist Ontario hospitals with meeting CCO’s
2008-2009 College of American Pathologists (CAP) / Collaborative
Staging (CS) aligned data standards for pathology reporting.
Standardized pathology reporting increases the availability and
consistency of cancer pathology information that is essential
for treatment decisions, evaluation and research. Over the past
two years, CCO has made substantial progress working with
hospitals. In an effort to continue to support them, CCO has
developed a process to certify specific vendor solutions against
defined reporting standards. The certification of a vendor
solution is the first step to validating that it can be
implemented or enhanced to assist the hospitals in meeting the
new standards.
Impac Software complies with the 2008-2009 CAP/CS aligned data
standards developed by Cancer Care Ontario in conjunction with
the College of American Pathologists (CAP) Cancer Committee, the
Centers for Disease Control and Prevention and the American
Joint Committee on Cancer. The CAP checklists1
for breast, colorectal, endometrium, lung and prostate were
amended to include the mandatory pathological collaborative
staging elements.
Impac’s PowerPath version 9.2.5 or higher should be able to
assist hospitals with meeting the new CCO reporting standards
for cancer-related pathology reporting in Ontario.
“We are very pleased to receive this certification for synoptic
reporting from Cancer Care Ontario. To comply with CCO’s
certification requirement, we developed new worksheets and added
them to our existing cancer protocol reporting suite – a feature
available to every new or upgraded PowerPath customer since
2006,” says George Rugg, Senior Vice President and General
Manager of Impac Software’s LIS business unit. “We have
considerable experience implementing the synoptic reporting tool
and are excited to work with laboratories in Ontario to meet
their reporting needs in the future.
Product Inquiries:
Julie DeSantis, Market Manager, Impac Software
408-830-8083 or
jdesantis@impac.com
About Impac Software
Impac Software is part of the Elekta Group, a human care company
pioneering significant innovations and clinical solutions for
treating cancer and brain disorders. Impac’s open integration to
multiple healthcare data and imaging systems offers
oncology-specific patient charting and practice management, as
well as best-of-breed systems for anatomic pathology, clinical
laboratory and cancer registry.
Today, Elekta solutions are used in more than 5,000 hospitals
globally, and every day more than 100,000 patients receive
diagnosis, treatment or follow-up with the help of a solution
from the Elekta Group.
Elekta employs around 2,500 employees globally. The corporate
headquarter is located in Stockholm, Sweden, and the company is
listed on the Nordic Exchange under the ticker EKTAb. For more
information about Elekta, please visit www.elekta.com.
About Cancer Care Ontario
Cancer Care Ontario is the provincial agency responsible for
continually improving cancer services. As the government’s
cancer advisor, Cancer Care Ontario works to reduce the number
of people diagnosed with cancer and make sure that patients
receive better care every step of the way.
1 This material includes the
Cancer Checklists and Cancer Protocols which are copyrighted
works of the College of American Pathologists. Encoded within
the Checklists are portions of the copyrighted work of the
International Health Terminology Standards Development
Organization, SNOMED CT. © 1998-2007 IHTSDO. The Cancer
Checklists and Cancer Protocols are used with permission of the
College of American Pathologists – which has also authorized use
of SNOMED CT as encoded in the Checklists. |
|
Media Inquiries:
Michelle Lee
PR and Advertising Manager
Tel: +1 770-670-2447
michelle.lee@elekta.com
Global Marketing inquiries:
Peter Ejemyr
Group VP,
Corporate Communications, Tel: +46 733 611 000
peter.ejemyr@elekta.com
Investor inquiries:
Lena Schattauer,
Investor Relations,
Elekta AB
Tel: +46 8 587 257 22, +46 70 595 51 00,
lena.schattauer@elekta.com
Link Disclaimer
|
